Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Advantage

Device Pelvic Organ Prolapse

Open in the dashboard

General payments

$52,551

267 payments

Research payments

$0

0 payments

Through program year 2020, $52,551 in general payments and $0 in research payments were reported against Advantage (Pelvic Organ Prolapse).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $7,333 12
2019 General $45,217 255

Breakdown

Who paid General payments · program years 2019–2020
  1. Boston Scientific Corporation $52,551 267 payments
Top recipients General payments · program year 2020
  1. Suzette Sutherland Urogynecology and Reconstructive Pelvic Surgery · Scottsdale, AZ $3,600 49% · 2 payments
  2. Amir Shariati Urogynecology and Reconstructive Pelvic Surgery · Coconut Creek, FL $2,660 36% · 1 payment
  3. Emily Myer Urogynecology and Reconstructive Pelvic Surgery · Woodbury, MN $720 10% · 1 payment
  4. Charbel Salamon Urogynecology and Reconstructive Pelvic Surgery · Orlando, FL $188 3% · 1 payment
  5. Eric Kuhn Urology · Cincinnati, OH $62 <1% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Urogynecology and Reconstructive Pelvic Surgery Urology $3,600 49% · 1 practitioner
  2. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $3,600 49% · 5 practitioners
  3. Urology $108 1% · 4 practitioners
  4. Obstetrics & Gynecology $25 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Washington $3,600 49% · 1 recipient
  2. Florida $2,660 36% · 1 recipient
  3. Minnesota $720 10% · 1 recipient
  4. New Jersey $188 3% · 1 recipient
  5. Ohio $62 <1% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

267 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record